Xploro®’s Post

🔍 #GetToKnowUs ! The PREVENTABLE project consortium partner: Helse Bergen Hf 🌟 🏥 Who They Are: Helse Bergen HF is a renowned healthcare institution dedicated to investing in medical and health-related research. Their comprehensive approach ensures both depth and breadth in various cutting-edge fields, making them a cornerstone in the healthcare community. 🔬 Key Focus Areas: a. Research and Innovation: Pioneering studies and breakthroughs that push the boundaries of medical science. b. Specialized Functions: Utilizing high expertise to provide research-based patient care tailored to individual needs. c. Education and Training: Shaping the future of healthcare by educating and training the next generation of health professionals. 🌟 Why It Matters: Helse Bergen HF’s commitment to research and innovation translates directly into improved patient care and outcomes. Their dedication to educating healthcare professionals ensures a continuous cycle of knowledge and expertise in the medical field. 🔗 Learn More: https://lnkd.in/dfrVHsgW #PREVENTABLE #RTRS #KnowAboutRTRS #rarediseases #horizoneurope #RareTumourRiskSyndromes #HelseBergenHF #MedicalResearch #HealthcareInnovation #PatientCare #MedicalEducation #FutureOfHealthcare #ResearchBasedCare #HealthcareExcellence

Discover how Daniel Health revolutionized efficiency and safety at Stanford School of Medicine! Our case study delves into the innovative strategies implemented across 26 facilities, transforming them into models of operational excellence. Learn how we're setting new standards in healthcare safety and efficiency. #HealthcareInnovation #PatientSafety

Did you know The Journal of Hospital Medicine is now on LinkedIn? 🙌 Follow along for the latest hospital medicine research and more! #MoreThanAJournal

Here is our study published in the New England Journal of Medicine Catalyst on the importance of PROMs for evaluating medical teams https://lnkd.in/ePy6ezFM

Happy 𝑪𝒍𝒊𝒏𝒊𝒄𝒂𝒍 𝑻𝒓𝒊𝒂𝒍𝒔 𝑫𝒂𝒚! ACRP - Association of Clinical Research Professionals asked everyone in this photo mosaic to share what this day means to them. To me, it means the opportunity to do my part to make an impact to the future of human health! Thank you to everyone who is part of the ecosystem of clinical trials and who makes the engine of innovation turn for patients who are waiting! **I've included the link to add your photo below** #ClinicalTrialsDay #CTD2024 #ClinicalTrials #ClinicalResearch #TrailblazersAmongUs

Dr Martin Johnson, Medical Director at FutureMeds UK, delivered a speech at a roundtable in April, encouraging industry leaders to      🎯 Explore the need for a professional body representing site management and clinical research organisations in the UK.     Hosted by The RSA Group and chaired by Lord James O'Shaughnessy, the roundtable concluded with      + unanimous support for establishing a professional body, and      + a shared vision of how it could benefit the sector as a whole and, more importantly, the patients.      "𝙒𝙝𝙞𝙡𝙚 𝙩𝙝𝙚 𝙩𝙖𝙨𝙠 𝙞𝙨 𝙙𝙖𝙪𝙣𝙩𝙞𝙣𝙜, 𝙩𝙝𝙚 𝙥𝙤𝙩𝙚𝙣𝙩𝙞𝙖𝙡 𝙧𝙚𝙬𝙖𝙧𝙙𝙨 𝙞𝙣 𝙩𝙚𝙧𝙢𝙨 𝙤𝙛 𝙚𝙣𝙝𝙖𝙣𝙘𝙚𝙙 𝙧𝙚𝙨𝙚𝙖𝙧𝙘𝙝 𝙚𝙛𝙛𝙞𝙘𝙖𝙘𝙮, 𝙞𝙢𝙥𝙧𝙤𝙫𝙚𝙙 𝙥𝙖𝙩𝙞𝙚𝙣𝙩 𝙤𝙪𝙩𝙘𝙤𝙢𝙚𝙨, 𝙖𝙣𝙙 𝙖 𝙢𝙤𝙧𝙚 𝙧𝙤𝙗𝙪𝙨𝙩 𝙧𝙚𝙨𝙚𝙖𝙧𝙘𝙝 𝙚𝙘𝙤𝙨𝙮𝙨𝙩𝙚𝙢 𝙞𝙣 𝙩𝙝𝙚 𝙐𝙆 𝙖𝙧𝙚 𝙘𝙤𝙢𝙥𝙚𝙡𝙡𝙞𝙣𝙜." Added Dr Martin Johnson     "𝙏𝙝𝙞𝙨 𝙢𝙚𝙚𝙩𝙞𝙣𝙜, 𝙩𝙝𝙚𝙧𝙚𝙛𝙤𝙧𝙚, 𝙬𝙖𝙨 𝙣𝙤𝙩 𝙟𝙪𝙨𝙩 𝙖 𝙘𝙖𝙡𝙡 𝙩𝙤 𝙖𝙘𝙩𝙞𝙤𝙣 — 𝙞𝙩 𝙬𝙖𝙨 𝙖 𝙨𝙩𝙚𝙥 𝙩𝙤𝙬𝙖𝙧𝙙 𝙧𝙚𝙖𝙡𝙞𝙨𝙞𝙣𝙜 𝙖 𝙫𝙞𝙨𝙞𝙤𝙣 𝙩𝙝𝙖𝙩 𝙘𝙤𝙪𝙡𝙙 𝙧𝙚𝙙𝙚𝙛𝙞𝙣𝙚 𝙩𝙝𝙚 𝙛𝙪𝙩𝙪𝙧𝙚 𝙤𝙛 𝙘𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝙧𝙚𝙨𝙚𝙖𝙧𝙘𝙝 𝙞𝙣 𝙩𝙝𝙚 𝙐𝙆."     We would like to express our gratitude to everyone who joined and contributed and to Caroline Hunt for bringing together several industry leaders to discuss this key topic.      Learn more: https://lnkd.in/e9-N7qxb    #ClinicalTrials #ClinicalResearch 

Two Clinical and Translational Science Awards (CTSA) Program institutions will support the rapid launch of #ClinicalResearch in rural primary care settings as part of the CARE for Health pilot program! #CTSAProgram institutions have a robust infrastructure, including expertise and resources, which speeds the translation of research discoveries into improved care. This is a crucial step toward ensuring all Americans benefit from medical care. Learn more about #CAREforHealth: https://lnkd.in/gA4-66Ai

Today, PMC launched the schedule & speaking line-up for its 18th Annual Personalized Medicine Conference, which will take place from Nov. 12 - 14 at Harvard Medical School in Boston. This conference asks what scientific progress and broad-based access to personalized medicine could mean for patients and health care systems around the world. During the past two decades, new scientific discoveries, not to mention industry investments, have driven to the market thousands of innovative tests and therapies that promise to help direct the right preventive and treatment interventions to the right patients at the right times. But clinical practice gaps and access challenges are leaving too many patients without the benefits that personalized medicine would provide. By rallying academic researchers, investors, business leaders, and health system administrators around a shared vision for the future of the field, PMC believes this conference, organized as it is by the nonprofit Coalition with the support of its more than 200 member institutions, will help pave the way for the advancement of personalized medicine, which can vastly improve the delivery of health care. Learn more and register here: https://lnkd.in/eZeNcNYf

Today we share Anne Wilson’s enlightening conversation with Professor David Putrino. We need dedicated research on bedbound patients – so often they are excluded from research because it is viewed as "too hard" to involve them, which is not the case. Making reasonable accommodations for bed- and house-bound patients to participate in research is, in fact, good and ethical research practice. In addition, we need comprehensive educational resources to share the knowledge of some of the physicians and clinicians who have experience in treating these patients, so that more clinicians can come to understand how to manage the care of these individuals. Too many patients living in this situation are viewed as "too difficult" and many clinicians don't even know where to begin. Skilled education can help here and can provide many clinicians with a roadmap of ways to improve quality of life for these individuals who are living in very tough conditions. Professor David Putrino, Director of Rehabilitation Innovation at Icahn School of Medicine at Mount Sinai Listen here: https://vist.ly/3a6f8

The success of a clinical research site ultimately depends on nobody else, but the site owner get my take on what the incentives are for small clinics to start doing clinical research in their communities as well as the two biggest fail points in this latest article https://lnkd.in/geGxC2sg